Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
The company is one of the most profitable companies manufacturing speciality chemicals in India
The term of O&M is for 15 years with a lock in period of 5 years for the Company and 15 years for VHPL & Bharathi Education trust.
The new facility will be able to handle four times as many patients as the previous facility.
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
Miravo to remain a Canadian controlled and operated company following closing of the transaction
Indira IVF integrates diagnostics services with a special focus on women & child care to increase accessibility for patients
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
The initiative has garnered the distinction of being the world’s largest government owned telemedicine platform
The new eye hospital in Vashi is ASG’s second in the Mumbai Metropolitan Region (MMR) and the sixth in Maharashtra
Subscribe To Our Newsletter & Stay Updated
